503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-0.53%
Negative net income growth while ORCL stands at 82.05%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
-23.81%
Negative yoy D&A while ORCL is 8.95%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
36.36%
Slight usage while ORCL is negative at -69.22%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative yoy inventory while ORCL is 0.00%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
No Data
No Data available this quarter, please select a different quarter.
159.26%
Some yoy usage while ORCL is negative at -69.22%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
No Data
No Data available this quarter, please select a different quarter.
0.88%
Operating cash flow growth below 50% of ORCL's 29.53%. Michael Burry would see a serious shortfall in day-to-day cash profitability.
-19.70%
Both yoy lines negative, with ORCL at -11.29%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
No Data
No Data available this quarter, please select a different quarter.
-264.03%
Negative yoy purchasing while ORCL stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
No Data
No Data available this quarter, please select a different quarter.
-581.48%
We reduce yoy other investing while ORCL is 343.80%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-217.54%
Both yoy lines negative, with ORCL at -29.43%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
-43.13%
Negative yoy issuance while ORCL is 135.34%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
-40.55%
We cut yoy buybacks while ORCL is 12.15%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.